Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Chalmers

Showing results (11-20 of 646) with videos related to

Pageof 65
Sort By:
The European Respiratory Journal|May 21, 2017
Macrolide resistance in <i>Pseudomonas aeruginosa</i>: implications for practiceJames D Chalmers
Seminars in Respiratory and Critical Care Medicine|July 14, 2021
Bronchiectasis: Advances in Diagnosis and TreatmentJames D Chalmers
Clinics in Chest Medicine|March 3, 2022
Bronchiectasis from 2012 to 2022James D Chalmers
American Journal of Respiratory and Critical Care Medicine|November 16, 2016
Microbial Dysbiosis after Lung TransplantationJames D Chalmers
Annals of the American Thoracic Society|March 2, 2018
Bronchiectasis Exacerbations Are Heart-BreakingJames D Chalmers
Transactions. Medico-Chirurgical Society of Edinburgh|March 28, 2018
Reasons for Abandoning the Uric Acid Theory of GoutD Chalmers Watson
QJM : Monthly Journal of the Association of Physicians|August 1, 2014
Community-acquired severity prediction-what are we predicting and why?J D Chalmers
Critical Care Medicine|January 18, 2014
Macrolides and mortality in severe community-acquired pneumoniaJames D Chalmers
Critical Care (London, England)|July 14, 2009
ICU admission and severity assessment in community-acquired pneumoniaJames D Chalmers
The Lancet. Respiratory Medicine|August 26, 2014
Bronchiectasis trials: losing the battle but winning the war?James D Chalmers
Pageof 65

Showing results (11-20 of 646) with videos related to

Sort By:
Pageof 65
The European Respiratory Journal|May 21, 2017
Macrolide resistance in <i>Pseudomonas aeruginosa</i>: implications for practiceJames D Chalmers
Seminars in Respiratory and Critical Care Medicine|July 14, 2021
Bronchiectasis: Advances in Diagnosis and TreatmentJames D Chalmers
Clinics in Chest Medicine|March 3, 2022
Bronchiectasis from 2012 to 2022James D Chalmers
American Journal of Respiratory and Critical Care Medicine|November 16, 2016
Microbial Dysbiosis after Lung TransplantationJames D Chalmers
Annals of the American Thoracic Society|March 2, 2018
Bronchiectasis Exacerbations Are Heart-BreakingJames D Chalmers
Transactions. Medico-Chirurgical Society of Edinburgh|March 28, 2018
Reasons for Abandoning the Uric Acid Theory of GoutD Chalmers Watson
QJM : Monthly Journal of the Association of Physicians|August 1, 2014
Community-acquired severity prediction-what are we predicting and why?J D Chalmers
Critical Care Medicine|January 18, 2014
Macrolides and mortality in severe community-acquired pneumoniaJames D Chalmers
Critical Care (London, England)|July 14, 2009
ICU admission and severity assessment in community-acquired pneumoniaJames D Chalmers
The Lancet. Respiratory Medicine|August 26, 2014
Bronchiectasis trials: losing the battle but winning the war?James D Chalmers
Pageof 65